Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03111173 · ClinicalTrials.gov registry record · NA
Can Conventional ECG Technology Capture Fetal Cardiac Activity?
A NA study of Fetal Monitoring, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03111173 is a NA study of Fetal Monitoring that is actively recruiting participants, run by University of Washington. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03111173, a NA study of Fetal Monitoring, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a feasibility study for a new application for capturing fetal cardiac activity. The objective of this study is to determine if it is feasible to capture a fetal ECG signal using a Holter ECG device. As comparison we will use a standard Doppler Fetal Heart Rate (FHR) device.
Conditions Studied
Interventions
- DEVICE Holter Device
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-06-02 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03111173
The ClinicalTrials.gov registry entry for NCT03111173 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fetal Monitoring appearing as the primary indexed condition, and to 1 intervention - of which Holter Device is the first listed.
NCT03111173 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT03111173 about?
NCT03111173 is a clinical study titled "Can Conventional ECG Technology Capture Fetal Cardiac Activity?". This is a feasibility study for a new application for capturing fetal cardiac activity. The objective of this study is to determine if it is feasible to capture a fetal ECG signal using a Holter ECG device. As comparison we will use a standard Doppler Fetal Heart Rate (FHR) device.
What is the current status of trial NCT03111173?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2017-06-02. Estimated completion is 2026-12.
What conditions does trial NCT03111173 study?
This clinical trial studies the following conditions: Fetal Monitoring.
What interventions are being tested in trial NCT03111173?
The interventions under investigation include: Holter Device (DEVICE).
Who is sponsoring clinical trial NCT03111173?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03111173 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.